Validation of the FACIT-Fatigue Scale in Patients With Locally Advanced or Metastatic Breast Cancer.

IF 4.2 2区 医学 Q1 ONCOLOGY
Oncologist Pub Date : 2025-09-26 DOI:10.1093/oncolo/oyaf292
Alessandra Fabi, Steven Hager, Laura Lourdes, Chiara Gandini, Elizabeth M Gavioli, Renuka Wakade, Enrico M Minnella, Marcello Allegretti
{"title":"Validation of the FACIT-Fatigue Scale in Patients With Locally Advanced or Metastatic Breast Cancer.","authors":"Alessandra Fabi, Steven Hager, Laura Lourdes, Chiara Gandini, Elizabeth M Gavioli, Renuka Wakade, Enrico M Minnella, Marcello Allegretti","doi":"10.1093/oncolo/oyaf292","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Cancer-related fatigue (CRF) is a common symptom in patients with locally advanced or metastatic breast cancer (LA/M BC) receiving taxane-based chemotherapy (CT). CRF is commonly assessed as a subjective experience by patient questionnaires, such as the Functional Assessment of Chronic Illness Therapy (FACIT)-Fatigue. The aim of this study was to extend validity of the FACIT-Fatigue and estimate clinically meaningful group-level differences in this patient population.</p><p><strong>Materials and methods: </strong>This was a prospective, noninterventional, multinational study conducted in the United States and Italy from October 2021 to August 2023 in adult patients with LA/M BC eligible to receive cycle 1 of taxane-based CT. Patients completed a FACIT-Fatigue survey before starting CT and every 3 to 4 weeks for ∼16 weeks; a group of patients participated in a qualitative substudy to explore additional fatigue factors via semistructured, phone-based cognitive interviews.</p><p><strong>Results: </strong>Sixty-two female patients with a mean (standard deviation) age of 55.5 (12.2) years were included. Baseline (visit 1) mean (95% confidence interval) FACIT-Fatigue score was 39.0 (36.8, 41.2), and fatigue worsened over time from 36.6 at visit 2 to 31.9 at visit 5. All FACIT-Fatigue items were relevant, with patients frequently reporting physical and psychological fatigue during treatment; the most highly relevant items were \"I feel listless\" and \"I have to limit my social activity because I am tired.\" Triangulation of anchor-based, distribution-based, and qualitative-based methods determined a meaningful group-level difference of 2.4 points.</p><p><strong>Conclusion: </strong>The FACIT-Fatigue survey includes items relevant to patients with LA/M BC on taxane-based CT.</p>","PeriodicalId":54686,"journal":{"name":"Oncologist","volume":" ","pages":""},"PeriodicalIF":4.2000,"publicationDate":"2025-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Oncologist","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/oncolo/oyaf292","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Cancer-related fatigue (CRF) is a common symptom in patients with locally advanced or metastatic breast cancer (LA/M BC) receiving taxane-based chemotherapy (CT). CRF is commonly assessed as a subjective experience by patient questionnaires, such as the Functional Assessment of Chronic Illness Therapy (FACIT)-Fatigue. The aim of this study was to extend validity of the FACIT-Fatigue and estimate clinically meaningful group-level differences in this patient population.

Materials and methods: This was a prospective, noninterventional, multinational study conducted in the United States and Italy from October 2021 to August 2023 in adult patients with LA/M BC eligible to receive cycle 1 of taxane-based CT. Patients completed a FACIT-Fatigue survey before starting CT and every 3 to 4 weeks for ∼16 weeks; a group of patients participated in a qualitative substudy to explore additional fatigue factors via semistructured, phone-based cognitive interviews.

Results: Sixty-two female patients with a mean (standard deviation) age of 55.5 (12.2) years were included. Baseline (visit 1) mean (95% confidence interval) FACIT-Fatigue score was 39.0 (36.8, 41.2), and fatigue worsened over time from 36.6 at visit 2 to 31.9 at visit 5. All FACIT-Fatigue items were relevant, with patients frequently reporting physical and psychological fatigue during treatment; the most highly relevant items were "I feel listless" and "I have to limit my social activity because I am tired." Triangulation of anchor-based, distribution-based, and qualitative-based methods determined a meaningful group-level difference of 2.4 points.

Conclusion: The FACIT-Fatigue survey includes items relevant to patients with LA/M BC on taxane-based CT.

局部晚期或转移性乳腺癌患者facit -疲劳量表的验证
背景:癌症相关性疲劳(CRF)是局部晚期或转移性乳腺癌(LA/M BC)接受紫杉烷化疗(CT)患者的常见症状。CRF通常通过患者问卷作为主观体验进行评估,例如慢性疾病治疗功能评估(FACIT)-疲劳。本研究的目的是延长FACIT-Fatigue的有效性,并估计该患者群体中有临床意义的组水平差异。材料和方法:这是一项前瞻性、非介入性、跨国研究,于2021年10月至2023年8月在美国和意大利进行,对象是有资格接受紫杉烷基CT第1周期治疗的LA/M型BC成年患者。患者在开始CT前完成facit -疲劳调查,每3至4周进行一次,持续~ 16周;一组患者参与了一项定性的子研究,通过半结构化的、基于电话的认知访谈来探索额外的疲劳因素。结果:纳入62例女性患者,平均(标准差)年龄为55.5(12.2)岁。基线(访问1)FACIT-Fatigue评分平均值(95%置信区间)为39.0(36.8,41.2),随着时间的推移,疲劳从访问2时的36.6恶化到访问5时的31.9。所有FACIT-Fatigue项目都是相关的,患者在治疗期间经常报告身体和心理疲劳;最相关的条目是“我感到无精打采”和“因为我累了,我不得不限制我的社交活动”。基于锚定法、基于分布法和基于定性法的三角测量确定了有意义的群体水平差异2.4点。结论:FACIT-Fatigue调查包括与紫杉烷基CT上LA/M型BC患者相关的项目。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Oncologist
Oncologist 医学-肿瘤学
CiteScore
10.40
自引率
3.40%
发文量
309
审稿时长
3-8 weeks
期刊介绍: The Oncologist® is dedicated to translating the latest research developments into the best multidimensional care for cancer patients. Thus, The Oncologist is committed to helping physicians excel in this ever-expanding environment through the publication of timely reviews, original studies, and commentaries on important developments. We believe that the practice of oncology requires both an understanding of a range of disciplines encompassing basic science related to cancer, translational research, and clinical practice, but also the socioeconomic and psychosocial factors that determine access to care and quality of life and function following cancer treatment.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信